June 10, 2024
Toronto, Ontario—The Society of Nuclear Medicine and Molecular Imaging recognized six new SNMMI Fellows today during a plenary session at the society’s 2024 Annual Meeting, held June 8-11 in Toronto. The SNMMI Fellowship was established in 2016 to recognize distinguished service to the society as well as exceptional achievement in the field of nuclear medicine and molecular imaging. It is among the most prestigious formal recognitions available to long-time SNMMI members.
In keeping with tradition, SNMMI’s 2023-24 president, Helen R. Nadel, MD, director of pediatric nuclear medicine at Lucile Packard Children’s Hospital at Stanford and clinical professor of radiology at the Stanford School of Medicine, in Stanford, California, was honored as an SNMMI Fellow following her term. Also recognized were:
Donna Cross, PhD, University of Utah, Salt Lake City, Utah
Frederick D. Grant, MD, Children’s Hospital of Philadelphia, Perelman School of Medicine, University of Pennsylvania, Philadelphia, Pennsylvania
Michael Hofman, MBBS, Peter MacCallum Cancer Centre, Melbourne, Australia
Heather Jacene, MD, Dana Farber Cancer Institute, Boston, Massachusetts
Andrew Scott, MD, Austin Hospital, Melbourne, Australia
Douglas Van Nostrand, MD, Washington Hospital Center, Washington, DC
Selection of SNMMI Fellows is based on documented excellence of volunteer service to the society and at least one of the additional three areas: excellence in scientific discovery and innovation, educational efforts in nuclear medicine and molecular imaging, or clinical practice of nuclear medicine and molecular imaging. SNMMI Fellowship is recognized with the designation FSNMMI.
About the Society of Nuclear Medicine and Molecular Imaging
The Society of Nuclear Medicine and Molecular Imaging (SNMMI) is an international scientific and medical organization dedicated to advancing nuclear medicine and molecular imaging—vital elements of precision medicine that allow diagnosis and treatment to be tailored to individual patients in order to achieve the best possible outcomes.
SNMMI’s members set the standard for molecular imaging and nuclear medicine practice by creating guidelines, sharing information through journals and meetings and leading advocacy on key issues that affect molecular imaging and therapy research and practice. For more information, visit www.snmmi.org.